DrugPatentWatch Database Preview
Drugs in Development Information for Mitoquinone
Email this page to a colleague
» See Plans and PricingWhat is the development status for investigational drug Mitoquinone?
Mitoquinone is an investigational drug.
There have been 6 clinical trials for Mitoquinone.
The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2010.
The most common disease conditions in clinical trials are Sclerosis, Multiple Sclerosis, and Fatigue. The leading clinical trial sponsors are Antipodean Pharmaceuticals, Inc., VA Office of Research and Development, and Oregon Health and Science University.
Summary for Mitoquinone
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 19 |
| WIPO Patent Applications | 8 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2010-11-01) |
| Vendors | 7 |
Recent Clinical Trials for Mitoquinone
| Title | Sponsor | Phase |
|---|---|---|
| MitoQ for Fatigue in Multiple Sclerosis (MS) | VA Office of Research and Development | Phase 1/Phase 2 |
| MitoQ on Fatigue in Multiple Sclerosis | MitoQ Ltd | Phase 1/Phase 2 |
| MitoQ on Fatigue in Multiple Sclerosis | Oregon Health and Science University | Phase 1/Phase 2 |
Clinical Trial Summary for Mitoquinone
Top disease conditions for Mitoquinone
Top clinical trial sponsors for Mitoquinone
US Patents for Mitoquinone
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
